499 genotypes with 513 annotations displayed
of selected term and subterms
|
Searched Term: increased susceptibility to autoimmune disorder
|
AA467197em1Nyam/AA467197em1Nyam
(C.B6-AA467197em1Nyam)
|
increased susceptibility to autoimmune disorder
|
J:347271
|
Ackr4tm1.1Rjbn/Ackr4tm1.1Rjbn
(B6.129S6-Ackr4tm1.1Rjbn)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:166490
|
Ads1NZB/Ads1NZB
(involves: NZB * NZW)
|
increased susceptibility to autoimmune disorder
|
J:7111
|
Ads1NZB/Ads1NZW
(involves: NZB * NZW)
|
increased susceptibility to autoimmune disorder
|
J:7111
|
Ads2NZB/Ads2NZB
(involves: NZB * NZW)
|
increased susceptibility to autoimmune disorder
|
J:7111
|
Ads2NZB/Ads2NZW
(involves: NZB * NZW)
|
increased susceptibility to autoimmune disorder
|
J:7111
|
Ads3NZB/Ads3NZW
(involves: NZB * NZW)
|
increased susceptibility to autoimmune disorder
|
J:7111
|
Ads3NZW/Ads3NZW
(involves: NZB * NZW)
|
increased susceptibility to autoimmune disorder
|
J:7111
|
Ads4NZB/Ads4NZW
(involves: NZB * NZW)
|
increased susceptibility to autoimmune disorder
|
J:7111
|
Ads4NZW/Ads4NZW
(involves: NZB * NZW)
|
increased susceptibility to autoimmune disorder
|
J:7111
|
Aec1NOD/Uf/Aec1NOD/Uf Aec2NOD/Uf/Aec2NOD/Uf
(B6.NOD-Aec2NOD/Uf Aec1NOD/Uf)
|
increased susceptibility to autoimmune disorder
|
J:128900
|
Agnm1MRL/MpJ/Agnm1MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
|
increased susceptibility to systemic lupus erythematosus
|
J:97786
|
Agnm2C3H/HeJ/Agnm2MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
|
increased susceptibility to systemic lupus erythematosus
|
J:97786
|
Agnm2MRL/MpJ/Agnm2MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
|
increased susceptibility to systemic lupus erythematosus
|
J:97786
|
Agnm3C3H/HeJ/Agnm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
|
increased susceptibility to systemic lupus erythematosus
|
J:97786
|
Agnm3MRL/MpJ/Agnm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
|
increased susceptibility to systemic lupus erythematosus
|
J:97786
|
Aia1NZB/Omr/Aia1NZB/Omr
(involves: NZB/Omr * NZC/Omr)
|
increased susceptibility to autoimmune hemolytic anemia
|
J:6517
|
Aia1NZB/Omr/Aia1NZC/Omr
(involves: NZB/Omr * NZC/Omr)
|
increased susceptibility to autoimmune hemolytic anemia
|
J:6517
|
Airetm1.1Doi/Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:83422
|
Airetm1Mand/Aire+
(NOD.129P2-Airetm1Mand)
|
increased susceptibility to autoimmune diabetes
|
J:135154,
J:188686
|
Airetm1Ptsn/Airetm1Ptsn
(C.B6-Airetm1Ptsn)
|
increased susceptibility to autoimmune disorder
|
J:174653
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
|
increased susceptibility to systemic lupus erythematosus
|
J:133606
|
Apoetm1Unc/Apoetm1Unc
(B6.Cg-Apoetm1Unc Faslpr)
|
increased susceptibility to systemic lupus erythematosus
|
J:133606
|
Apoetm1Unc/Apoetm1Unc Faslpr/Faslpr
(MRL.Cg-Apoetm1Unc Faslpr)
|
increased susceptibility to systemic lupus erythematosus
|
J:133606
|
Asbb1BALB/c/Asbb1BALB/c
(involves: BALB/c * C57BL/6J)
|
increased susceptibility to systemic lupus erythematosus
|
J:76486
|
Asbb2BALB/c/Asbb2C57BL/6J
(involves: BALB/c * C57BL/6J)
|
increased susceptibility to systemic lupus erythematosus
|
J:76486
|
Asbb2C57BL/6J/Asbb2C57BL/6J
(involves: BALB/c * C57BL/6J)
|
increased susceptibility to systemic lupus erythematosus
|
J:76486
|
Asbb3C57BL/6J/Asbb3C57BL/6J
(involves: BALB/c * C57BL/6J)
|
increased susceptibility to systemic lupus erythematosus
|
J:76486
|
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
(B6.FVB-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu)
|
increased susceptibility to autoimmune disorder
|
J:208213
|
increased susceptibility to induced arthritis
|
J:208213
|
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu Il6tm1Kopf/Il6tm1Kopf
(B6.Cg-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu Il6tm1Kopf)
|
increased susceptibility to induced arthritis
|
J:208213
|
Atg5tm1Myok/Atg5tm1Myok Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv)
|
increased susceptibility to systemic lupus erythematosus
|
J:235399
|
Atg7tm1Tchi/Atg7tm1Tchi Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)
|
increased susceptibility to systemic lupus erythematosus
|
J:235399
|
Aviltm2(cre)Fawa/Aviltm2(cre)Fawa
(B6J.129P2-Aviltm2(cre)Fawa)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:265529
|
B2mtm1Unc/B2mtm1Unc Tg(B2M)55Hpl/Tg(B2M)55Hpl Mcph1Tg(HLA-A2.1)1Enge/Mcph1Tg(HLA-A2.1)1Enge
(NOD.Cg-B2mtm1Unc Mcph1Tg(HLA-A2.1)1Enge Tg(B2M)55Hpl)
|
increased susceptibility to autoimmune diabetes
|
J:109851
|
B2mtm1Unc/B2mtm1Unc Tg(HLA-A/H2-D/B2M)1Dvs/0
(NOD.Cg-B2mtm1Unc Tg(HLA-A/H2-D/B2M)1Dvs)
|
increased susceptibility to autoimmune diabetes
|
J:121685
|
B2mtm1Unc/B2mtm1Unc X/Yaa
(BXSB.129P2(B6)-B2mtm1Unc/Dcr)
|
increased susceptibility to systemic lupus erythematosus
|
J:179430
|
Bak1tm1Thsn/Bak1tm1Thsn Baxtm1Sjk/Baxtm2Sjk Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased susceptibility to autoimmune disorder
|
J:100463
|
Bcl2l11tm1.1Ast/Bcl2l11+
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:58641
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:58641
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast Faslpr/Faslpr
(B6.Cg-Bcl2l11tm1.1Ast Faslpr)
|
increased susceptibility to autoimmune disorder
|
J:132217
|
Becn1tm1Ebr/Becn1tm1Ebr Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
increased susceptibility to systemic lupus erythematosus
|
J:235399
|
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129S2/SvPas)
|
increased susceptibility to systemic lupus erythematosus
|
J:287636
|
Btlatm1Kmm/Btlatm1Kmm
(involves: 129S/SvEv)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:84084
|
Btn2a2tm1.2Wrth/Btn2a2tm1.2Wrth
(C57BL/6-Btn2a2tm1.2Wrth)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:232636
|
C1qatm1Mjw/C1qatm1Mjw Sle16129S6/SvEvTac/Sle16129S6/SvEvTac
(involves: 129S/SvEv * 129X1/Sv * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:118645
|
C1qatm1Mjw/C1qatm1Mjw Sle16129S6/SvEvTac/Sle16C57BL/6
(involves: 129S/SvEv * 129X1/Sv * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:118645
|
C1qatm1Mjw/C1qatm1Mjw Sle18C57BL/6/Sle18C57BL/6
(involves: 129S/SvEv * 129X1/Sv * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:118645
|
C1qatm1Mjw/C1qatm1Mjw Sle18C57BL/6/Sle18C57BL/6
(involves: 129P2/Ola * 129S/SvEv * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:118645
|
C1qatm1Mjw/C1qatm1Mjw Sle19C57BL/6/?
(involves: 129S/SvEv * 129X1/Sv * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:118645
|
C1qatm1Mjw/C1qatm1Mjw Sle19C57BL/6/?
(involves: 129P2/Ola * 129S/SvEv * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:118645
|
C1qatm1Mjw/C1qatm1Mjw Sle21129P2/Ola/? Sle18C57BL/6/Sle18C57BL/6
(involves: 129P2/Ola * 129S/SvEv * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:118645
|
C1qatm1Mjw/C1qatm1Mjw Sle21129P2/Ola/Sle21129P2/Ola
(involves: 129P2/Ola * 129S/SvEv * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:118645
|
C1qatm1Mjw/C1qatm1Mjw Sle21129P2/Ola/Sle21C57BL/6
(involves: 129P2/Ola * 129S/SvEv * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:118645
|
C1qtnf3tm1Yiw/C1qtnf3tm1Yiw
(involves: C57BL/6NSlc)
|
increased susceptibility to induced arthritis
|
J:211893
|
C1qtnf6tm1Yiw/C1qtnf6tm1Yiw
(B6.129P2-C1qtnf6tm1Yiw)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:227217
|
increased susceptibility to induced arthritis
|
J:227217
|
C9orf72tm1.1Eggn/C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N)
|
increased susceptibility to autoimmune disorder
|
J:240357
|
C9orf72tm1Eggn/C9orf72tm1Eggn
(involves: C57BL/6 * C57BL/6N)
|
increased susceptibility to autoimmune disorder
|
J:240357
|
Cblbtm1Hua/Cblbtm1Hua
(B6.129P2-Cblbtm1Hua)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:94685
|
Cblbtm1Hua/Cblbtm1Hua Ubash3btm1Jni/Ubash3btm1Jni Ubash3atm1Jni/Ubash3atm1Jni
(Not Specified)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:89761
|
Ccr7tm1Rfor/Ccr7tm1Rfor
(B6.129P2-Ccr7tm1Rfor)
|
increased susceptibility to autoimmune disorder
|
J:110910
|
Cd1d1tm1Luc/Cd1d1tm1Luc Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129-Cd1d1tm1Luc Cx3cr1tm1Litt)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:129712
|
Cd4tm1Knw/Cd4tm1Knw Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0
(NOD.Cg-Cd4tm1Knw Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)
|
increased susceptibility to autoimmune diabetes
|
J:93553
|
Cd8atm1Mak/Cd8atm1Mak Il15tm1Imx/Il15tm1Imx X/Yaa
(BXSB.Cg-Cd8atm1Mak Il15tm1Imx/Dcr)
|
increased susceptibility to systemic lupus erythematosus
|
J:179430
|
Cd8atm1Mak/Cd8atm1Mak X/Yaa
(BXSB.129S2(B6)-Cd8atm1Mak/4Dcr)
|
increased susceptibility to systemic lupus erythematosus
|
J:179430
|
Cd19tm1(cre)Cgn/Cd19+ Ep300tm2Reck/Ep300+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:147840
|
Cd19tm1(cre)Cgn/Cd19+ Ep300tm2Reck/Ep300+
(involves: 129/Sv * 129P2/OlaHsd * FVB/N)
|
increased susceptibility to systemic lupus erythematosus
|
J:147840
|
Cd19tm1(cre)Cgn/Cd19+ Ptpn6tm1Rsky/Ptpn6tm1Rsky
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:123568
|
Cd19tm1(cre)Cgn/Cd19+ Tnfaip3tm2Ama/Tnfaip3+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:163917
|
Cd19tm1Tft/Cd19tm1Tft
(B6.Cg-Cd19tm1Tft)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:106487
|
Cd28tm1Ltu/Cd28tm1Ltu Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:194503
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:194503
|
Cd28tm1Mak/Cd28tm1Mak
(NOD.129S2-Cd28tm1Mak)
|
increased susceptibility to autoimmune diabetes
|
J:93421
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * NOD)
|
increased susceptibility to autoimmune diabetes
|
J:35353
|
Cd28tm1Mak/Cd28tm1Mak Cd40lgtm1Flv/Cd40lgtm1Flv
(NOD.Cg-Cd40lgtm1Flv Cd28tm1Mak)
|
increased susceptibility to autoimmune diabetes
|
J:93421
|
Cd28tm1Shr/Cd28tm1Shr Ctla4tm1Shr/Ctla4+
(C.129S4-Cd28tm1Shr Ctla4tm1Shr)
|
increased susceptibility to autoimmune disorder
|
J:125259
|
Cd38tm1Lnd/Cd38tm1Lnd
(NOD.129P2(B6)-Cd38tm1Lnd/LtJ)
|
increased susceptibility to autoimmune diabetes
|
J:108097
|
Cd44tm1Mak/Cd44tm1Mak
(D1.129P2-Cd44tm1Mak)
|
increased susceptibility to induced arthritis
|
J:95275
|
Cd55tm1Mme/Cd55tm1Mme
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to experimental autoimmune myasthenia gravis
|
J:80116
|
Cd55tm1Song/Cd55tm1Song
(B6.129S6-Cd55tm1Song)
|
increased susceptibility to experimental autoimmune myasthenia gravis
|
J:113567
|
Cd55tm1Song/Cd55tm1Song Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd55tm1Song Cd59atm1Bpm)
|
increased susceptibility to experimental autoimmune myasthenia gravis
|
J:113567
|
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129 * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:89014
|
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129)
|
increased susceptibility to induced arthritis
|
J:146711
|
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm)
|
increased susceptibility to experimental autoimmune myasthenia gravis
|
J:113567
|
Cd72c/Cd72c Faslpr/Faslpr
(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)
|
increased susceptibility to systemic lupus erythematosus
|
J:204782
|
Cd74tm2Liz/Cd74tm2Liz
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:72243
|
Cd74tm3Liz/Cd74tm3Liz
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:72243
|
Cd79atm1(cre)Reth/Cd79a+ Inpp5dtm1Rav/Inpp5dtm1Rav
(involves: 129 * BALB/c * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:178833
|
Cd80tm1Shr/Cd80tm1Shr Cd86tm2Shr/Cd86tm2Shr
(involves: 129S4/SvJae)
|
increased susceptibility to autoimmune diabetes
|
J:113109
|
Cd80tm1Shr/Cd80tm1Shr Cd86tm2Shr/Cd86tm2Shr
(involves: 129S4/SvJae * NOD)
|
increased susceptibility to autoimmune diabetes
|
J:61905
|
Cd80tm1Shr/Cd80tm1Shr Cd86tm2Shr/Cd86tm2Shr
(129.SJL-Cd86tm2Shr)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:78992
|
Cd86tm1Shr/Cd86tm1Shr
(NOD.129S4-Cd86tm1Shr)
|
increased susceptibility to autoimmune diabetes
|
J:93421
|
Cd200tm1Jods/Cd200tm1Jods
(C57BL/6-Cd200tm1Jods)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:65982
|
increased susceptibility to experimental autoimmune uveoretinitis
|
J:79906
|
increased susceptibility to induced arthritis
|
J:65982
|
Cd247tm2.1Lov/Cd247tm2.1Lov
(B6.Cg-Cd247tm2.1Lov)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:192915
|
Cd274tm1.1Lex/Cd274tm1.1Lex
(involves: 129S5/SvEvBrd)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:126829
|
Cd274tm1Lpc/Cd274tm1Lpc
(B6.129S-Cd274tm1Lpc)
|
increased susceptibility to autoimmune disorder
|
J:89781
|
Cd274tm1Lpc/Cd274tm1Lpc
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:142815
|
Cd274tm1Lpc/Cd274tm1Lpc
(C.129S-Cd274tm1Lpc)
|
increased susceptibility to induced arthritis
|
J:165841
|
Cd274tm1Shr/Cd274tm1Shr
(C.B6-Cd274tm1Shr)
|
increased susceptibility to autoimmune diabetes
|
J:123785
|
Cd274tm1Shr/Cd274tm1Shr Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6)
|
increased susceptibility to autoimmune diabetes
|
J:153040
|
Cd276tm1Mak/Cd276tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:84973
|
Cd300lftm1Gne/Cd300lftm1Gne
(involves: C57BL/6N)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:156819
|
Cdk2tm2Sgo/Cdk2tm2Sgo Cdk4tm2.1Bbd/Cdk4tm2.1Bbd Polr2atm1(cre/ERT2)Bbd/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased susceptibility to autoimmune diabetes
|
J:125217
|
Ceat1CBA/J/Ceat1NOD
(involves: CBA/J * NOD-H2k)
|
increased susceptibility to experimental autoimmune thyroiditis
|
J:77545
|
Ceat1NOD/Ceat1NOD
(involves: CBA/J * NOD-H2k)
|
increased susceptibility to experimental autoimmune thyroiditis
|
J:77545
|
Cgnz1NZM2328/J/Cgnz1NZM2328/J
(involves: C57L/J * NZM2328/J)
|
increased susceptibility to systemic lupus erythematosus
|
J:71397
|
Cia2DBA/1J/Cia2DBA/1J
(involves: DBA/1J * FVB/N)
|
increased susceptibility to induced arthritis
|
J:116665
|
Cia7DBA/1J/Cia7DBA/1J
(involves: B10.Q * DBA/1)
|
increased susceptibility to induced arthritis
|
J:122130
|
Cia35C57BL/10SnSg/Cia35DBA/1J
(involves: C57BL/10 * DBA/1J)
|
increased susceptibility to induced arthritis
|
J:122130
|
Cia37C57BL/10SnSg/Cia37DBA/1J
(involves: C57BL/10 * DBA/1J)
|
increased susceptibility to induced arthritis
|
J:122130
|
Cia38DBA/1J/Cia38DBA/1J
(involves: C57BL/10 * DBA/1J)
|
increased susceptibility to induced arthritis
|
J:122130
|
Cia40C57BL/10SnSg/Cia40C57BL/10SnSg
(involves: C57BL/10SnSg * DBA/1J * NFS/N)
|
increased susceptibility to induced arthritis
|
J:106522
|
Cia43DBA/1J/Cia43FVB/N
(involves: DBA/1J * FVB/N)
|
increased susceptibility to induced arthritis
|
J:146242
|
Cia43FVB/N/Cia43FVB/N
(involves: DBA/1J * FVB/N)
|
increased susceptibility to induced arthritis
|
J:146242
|
Clec4a2tm1Yiw/Clec4a2tm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to induced arthritis
|
J:217720
|
Cntftm1Mpin/Cntftm1Mpin
(B6.129S2-Cntftm1Mpin)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:126852
|
Coro1aLmb3-MRL/MpScr/Coro1aLmb3-MRL/MpScr
(B6.MRL-Coro1aMRL/MpScr Faslpr)
|
increased susceptibility to systemic lupus erythematosus
|
J:125557
|
Cry1tm1Jhjh/Cry1tm1Jhjh Cry2tm1Jhjh/Cry2tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:159504
|
Csf3tm1Ard/Csf3tm1Ard Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak/0
(involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:155575
|
Cx3cr1tm1Litt/Cx3cr1+
(B6.129P2-Cx3cr1tm1Litt)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:129712
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:129712
|
Cxcl10tm1Adl/Cxcl10tm1Adl
(B6.129S4-Cxcl10tm1Adl)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:87076
|
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din/J)
|
increased susceptibility to systemic lupus erythematosus
|
J:235399
|
Cyp19a1tm1Sih/Cyp19a1tm1Sih
(involves: 129S/SvEv)
|
increased susceptibility to autoimmune disorder
|
J:216958
|
Cytl1tm1Chun/Cytl1tm1Chun
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:175377
|
DbaclC57BL/6Jcl/DbaclC57BL/6Jcl
(NOD.B6-(D4Mit193-D4Mit17))
|
increased susceptibility to autoimmune diabetes
|
J:144964
|
Dicer1tm1Tara/Dicer1tm1Tara Foxn1tm3(cre)Nrm/Foxn1+
(involves: 129P2/OlaHsd * C57BL/6NHsd)
|
increased susceptibility to induced arthritis
|
J:180783
|
Dnase1tm1Tmo/Dnase1tm1Tmo
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:62549
|
Dnase1tm2092.1Arte/Dnase1tm2092.1Arte
(involves: C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:277126
|
Dusp1tm1Lex/Dusp1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:126383
|
Dusp14Gt(OST210117)Lex/Dusp14Gt(OST210117)Lex
(B6.129S5-Dusp14Gt(OST210117)Lex)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:209403
|
Dusp22tm1Tht/Dusp22tm1Tht
(B6.129S7-Dusp22tm1Tht)
|
increased susceptibility to autoimmune disorder
|
J:213253
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:213253
|
E2f1tm1Meg/E2f1tm1Meg
(NOD.Cg-E2f1tm1Meg)
|
increased susceptibility to autoimmune diabetes
|
J:93708
|
E2f2tm1Zubi/E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:76318
|
E2f2tm1Zubi/E2f2tm1Zubi Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J)
|
increased susceptibility to autoimmune disorder
|
J:76318
|
Eae1A/J/Eae1A/J
(involves: A/J * C57BL/10SnJ)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:30574
|
Eae1PL/J/Eae1PL/J
(involves: C57BL/10SnJ * PL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:30574
|
Eae4ABH/?
(involves: ABH * NOD)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:29171
|
Eae5B10.S/DvTe/Eae5SJL/J
(involves: B10.S/DvTe * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:49054
|
Eae5SJL/J/Eae5SJL/J
(involves: B10.S/DvTe * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:49054
|
Eae7B10.S/DvTe/Eae7B10.S/DvTe
(involves: B10.S/DvTe * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:49054
|
Eae7B10.S/DvTe/Eae7SJL/J
(involves: B10.S/DvTe * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:49054
|
Eae10SJL/J/Eae10SJL/J
(involves: B10.S/DvTe * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:49054
|
Eae11SJL/J/?
(involves: B10.S/DvTe * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:53193
|
Eae12SJL/J/Eae12SJL/J
(involves: B10.S/DvTe * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:53193
|
Eae13SJL/J/?
(involves: B10.S/DvTe * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:53193
|
Eae14C57BL/10/?
(involves: B10.S/DvTe * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:69083
|
Eae17SJL/J/?
(involves: B10.S/DvTe * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:69083
|
Eae26B10.RIII/Eae26B10.RIII
(involves: B10.RIII * RIIIS/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:73850
|
Eae26B10.RIII/Eae26RIIIS/J
(involves: B10.RIII * RIIIS/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:73850
|
Eae33C57BL/10SnSg/?
(involves: B10.S * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:99793
|
Eae34C57BL/10SnSg/?
(involves: B10.S * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:99793
|
Eae35C57BL/10SnSg/?
(involves: B10.S * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:99793
|
Eae36SJL/J/?
(involves: B10.S * SJL/J)
|
increased susceptibility to autoimmune disorder
|
J:99793
|
Eae37C57BL/10SnSg/?
(involves: B10.S * SJL/J)
|
increased susceptibility to autoimmune disorder
|
J:99793
|
Eae38C57BL/10SnSg/?
(involves: B10.S * SJL/J)
|
increased susceptibility to autoimmune disorder
|
J:99793
|
Eae42SJL/J/?
(involves: B10.S * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:34892
|
Eae43B10.S/DvTe/?
(involves: B10.S/DvTe * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:53193
|
Eae43B10.S/DvTe/Eae43B10.S/DvTe
(involves: B10.S/DvTe * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:49054
|
Eae44aB10.S/DvTe/Eae44aB10.S/DvTe
(involves: B10.S/DvTe * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:56752
|
Ecm1tm1Bsun/Ecm1tm1Bsun
(involves: 129 * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:168252
|
Edil3Tg(lacZ)1Tq/Edil3Tg(lacZ)1Tq
(Not Specified)
|
increased susceptibility to induced arthritis
|
J:254384
|
Entpd7tm1Ktak/Entpd7tm1Ktak
(B6.Cg-Entpd7tm1Ktak)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:191188
|
Ergtm1.1Iwamo/Ergtm1.1Iwamo Tg(Gdf5-cre,-ALPP)1Kng/?
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
increased susceptibility to induced arthritis
|
J:243715
|
Faslpr/Faslpr
(MRL/Mp-Faslpr)
|
increased susceptibility to autoimmune disorder
|
J:108760
|
Faslpr/Faslpr
(MRL/MpJ-Faslpr/J)
|
increased susceptibility to systemic lupus erythematosus
|
J:92084
|
Faslpr/Faslpr
(involves: C3H * MRL/Mp)
|
increased susceptibility to systemic lupus erythematosus
|
J:34296
|
Faslpr/Faslpr Havcr1tm1Kuch/Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch Faslpr)
|
increased susceptibility to systemic lupus erythematosus
|
J:186484
|
Faslpr/Faslpr Ifnar1tm1Agt/Ifnar1tm1Agt
(MRL.Cg-Ifnar1tm1Agt Faslpr)
|
increased susceptibility to systemic lupus erythematosus
|
J:92084
|
Faslpr/Faslpr Ifnar1tm1Agt/Ifnar1tm1Agt Ifngr1tm1Agt/Ifngr1tm1Agt
(MRL.Cg-Ifngr1tm1Agt Ifnar1tm1Agt Faslpr)
|
increased susceptibility to systemic lupus erythematosus
|
J:92084
|
Faslpr/Faslpr Itfg2Gt(OST215121)Lex/Itfg2Gt(OST215121)Lex
(involves: 129S5/SvEvBrd * C57BL/6J * MRL/Mp)
|
increased susceptibility to systemic lupus erythematosus
|
J:205951
|
Faslpr/Faslpr Tg(INS-Il10)#Sar/0
(NOD.Cg-Faslpr Tg(INS-Il10)#Sar)
|
increased susceptibility to autoimmune diabetes
|
J:64051
|
Faslpr/Faslpr Tlr9tm1Aki/Tlr9tm1Aki
(MRL.Cg-Tlr9tm1Aki Faslpr)
|
increased susceptibility to systemic lupus erythematosus
|
J:113557
|
Faslpr/Faslpr Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(MRL.Cg-Tnfrsf9tm1Byk Faslpr)
|
increased susceptibility to systemic lupus erythematosus
|
J:127197
|
Fastm1Vbo/Fastm1Vbo Tg(Ins2-cre)25Mgn/0 Tg(Ins2-HA)165Bri/0 Tg(Tcra/Tcrb)1Vbo/0
(Not Specified)
|
increased susceptibility to autoimmune diabetes
|
J:85985
|
Faslgld/Faslgld
(involves: C3H/HeJ * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:153501
|
Fasltm1.1Ast/Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:153501
|
Fcgr2btm1.2Jsv/Fcgr2b+ X/Yaa
(involves: C57BL/6 * FVB/N * SB/Le)
|
increased susceptibility to systemic lupus erythematosus
|
J:179175
|
Fcgr2btm1.2Jsv/Fcgr2btm1.2Jsv Sle16C57BL/6/Sle16C57BL/6
(involves: C57BL/6 * FVB/N)
|
increased susceptibility to induced arthritis
|
J:179175
|
Fcgr2btm1Kgcs/Fcgr2b+
(involves: C57BL/6)
|
increased susceptibility to induced arthritis
|
J:190890
|
Fcgr2btm1Ttk/Fcgr2btm1.2Jsv Sle21129P2/Ola/Sle21C57BL/6
(involves: 129P2/Ola * 129S4/SvJae * C57BL/6 * FVB/N)
|
increased susceptibility to systemic lupus erythematosus
|
J:179175
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(Not Specified)
|
increased susceptibility to induced arthritis
|
J:106191
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk Sle21129P2/Ola/Sle21129P2/Ola
(B6.129S4-Fcgr2btm1Ttk)
|
increased susceptibility to induced arthritis
|
J:179175
|
increased susceptibility to systemic lupus erythematosus
|
J:179175
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to autoimmune diabetes
|
J:122114
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk Tlr7tm1Flv/Y X/Yaa
(B6.Cg-Fcgr2btm1Ttk Tlr7tm1Flv Yaa)
|
increased susceptibility to systemic lupus erythematosus
|
J:127600
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk Traf3ip2tm1Sbn/Traf3ip2+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:191090
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk X/Yaa
(B6.Cg-Fcgr2btm1Ttk Yaa)
|
increased susceptibility to systemic lupus erythematosus
|
J:127600
|
Fen1tm3.1Bhsh/Fen1+
(Not Specified)
|
increased susceptibility to autoimmune disorder
|
J:231218
|
Fen1tm3.1Bhsh/Fen1tm3.1Bhsh
(Not Specified)
|
increased susceptibility to autoimmune disorder
|
J:231218
|
Ffar2tm1Dgen/Ffar2tm1Dgen
(involves: C57BL/6)
|
increased susceptibility to induced arthritis
|
J:153951
|
Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to autoimmune disorder
|
J:82560
|
Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:117743
|
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:117743
|
Foxp3tm1Ayr/Y Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased susceptibility to autoimmune disorder
|
J:97029
|
Foxp3tm2.1(EGFP/cre)Shori/Y Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129 * 129S2/SvPas * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:234397
|
Foxp3tm3(HBEGF/GFP)Ayr/Foxp3tm3(HBEGF/GFP)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:117743
|
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr Ikzf4tm1Djr/Ikzf4tm1Djr
(involves: 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:294549
|
Fpr2tm1Rjf/Fpr2tm1Rjf
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:159658
|
Fyntm1Yik/Fyntm1Yik
(involves: C57BL/6 * CBA)
|
increased susceptibility to experimental autoimmune uveoretinitis
|
J:99347
|
Gadd45btm1Flv/Gadd45btm1Flv
(B6.129S6-Gadd45btm1Flv)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:118837
|
Gna12tm1Citb/Gna12tm1Citb Gna13tm2.1Soff/Gna13tm2.1Soff Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased susceptibility to autoimmune diabetes
|
J:149560
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(Ins2-CD80)3B7Flv/0
(B6.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv Tg(Ins2-CD80)3B7Flv)
|
increased susceptibility to autoimmune diabetes
|
J:59245
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA)
|
increased susceptibility to autoimmune diabetes
|
J:68641
|
H2-D1b-em5Dvs/H2-D1b-em5Dvs H2-K1d-em1Dvs/H2-K1d-em1Dvs Tg(HLA-A/H2-D/B2M)1Dvs/?
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-D1b-em5Dvs Tg(HLA-A/H2-D/B2M)1Dvs/Dvs)
|
increased susceptibility to autoimmune diabetes
|
J:257229
|
H2-D1b-em5Dvs/H2-D1b-em5Dvs H2-K1d-em1Dvs/H2-K1d-em1Dvs Tg(HLA-B39/H2-D/B2m)2Dvs/?
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-D1b-em5Dvs Tg(HLA-B39/H2-D/B2M)2Dvs/Dvs)
|
increased susceptibility to autoimmune diabetes
|
J:257229
|
H2-D1b-tm1Bpe/H2-D1b-tm1Bpe H2-K1b-tm1Bpe/H2-K1b-tm1Bpe X/Yaa
(BXSB.129P2(B6)-H2-K1b-tm1Bpe H2-D1b-tm1Bpe/Dcr)
|
increased susceptibility to systemic lupus erythematosus
|
J:179430
|
H2-T23tm1Cant/H2-T23tm1Cant
(involves: 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:89808
|
H2-T23tm2Cant/H2-T23tm2Cant Tg(Tcra2D2,Tcrb2D2)1Kuch/?
(involves: 129S6/SvEvTac)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:142087
|
H2-T23tm3Cant/H2-T23tm3Cant
(B6.129S6-H2-T23tm3Cant)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:142087
|
H2dlAb1-Ea/H2dlAb1-Ea Tg(HLA-DRA,HLA-DRB5*0101)hiKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:189816
|
H2dlAb1-Ea/H2dlAb1-Ea Tg(HLA-DRA,HLA-DRB5*0101)loKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:189816
|
H2g7/H2g7 Ins2tm1Jja/Ins2tm1Jja Rag1tm1Mom/Rag1tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
increased susceptibility to autoimmune diabetes
|
J:111874
|
H2g7/H2g7 Rag1tm1Mom/Rag1tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
increased susceptibility to autoimmune diabetes
|
J:111874
|
H2g7/H2g7 Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0
(B6.NOD-(D17Mit21-D17Mit10) Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)
|
increased susceptibility to autoimmune diabetes
|
J:167508
|
H2g7/H2q Rag1tm1Mom/Rag1tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
increased susceptibility to autoimmune diabetes
|
J:111874
|
H2k/H2k
(NOD.Cg-H2k)
|
increased susceptibility to autoimmune diabetes
|
J:14178
|
H2q/? Ncf1m1J/Ncf1m1J
(B6.Cg-Ncf1m1J H2q)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:92437
|
increased susceptibility to induced arthritis
|
J:92437
|
H2u/H2u Rag1tm1Mom/Rag1tm1Mom Tg(Tcra19,Tcrb19)#Stl/0
(either: (involves: 129S7/SvEvBrd * C57BL/6 * PL/J) or (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/10 * PL/J))
|
increased susceptibility to autoimmune disorder
|
J:19795
|
H2u/H2u Tg(Tcra19,Tcrb19)#Stl/0
(either: (involves: C57BL/6 * PL/J) or (involves: C57BL/6 * C57BL/10 * PL/J))
|
increased susceptibility to autoimmune disorder
|
J:19795
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:19795
|
H2u/H2u Tg(TCRA)B1Jg/? Tg(TCRB)C14Jg/?
(involves: C57BL/6 * C57BL/10SnSg * DBA/2 * PL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:92991
|
Hc1/? Tg(TcrbBL17)1Lmor/0
(involves: DBA/1J * SWR/J)
|
increased susceptibility to induced arthritis
|
J:134111
|
Hcsttm1.1Dnax/Hcsttm1.1Dnax
(involves: C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:148086
|
Hmox1tm1.1Gkl/Hmox1tm1.1Gkl Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:148498
|
HrUSP/HrUSP
(either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2))
|
increased susceptibility to autoimmune disorder
|
J:21316
|
Hrh3Eae8-s/?
(involves: B10.S * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:49054
|
Hrh3tm1Twl/Hrh3tm1Twl
(B6.129X1-Hrh3tm1Twl)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:122269
|
Icostm1Flv/Icostm1Flv
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:87123
|
Idd3A/J/Idd3A/J
(NOD.A-Idd3A/J)
|
increased susceptibility to autoimmune diabetes
|
J:120349
|
Idd3CAST/EiJ/Idd3CAST/EiJ
(NOD.CAST-Idd3CAST/EiJ)
|
increased susceptibility to autoimmune diabetes
|
J:120349
|
Idd3SWR/J/Idd3SWR/J
(NOD.SWR-Idd3SWR/J)
|
increased susceptibility to autoimmune diabetes
|
J:120349
|
Idd4.3C57L/Idd4.3C57L
(involves: C57L/J * NOD)
|
increased susceptibility to autoimmune diabetes
|
J:118951
|
Ifih1Rgsc422/Ifih1+
(D2JJcl.B6JJcl-Ifih1Rgsc422)
|
increased susceptibility to systemic lupus erythematosus
|
J:209917
|
Ifih1Rgsc422/Ifih1Rgsc422
(D2JJcl.B6JJcl-Ifih1Rgsc422)
|
increased susceptibility to systemic lupus erythematosus
|
J:209917
|
Ifnb1tm1Tl/Ifnb1tm1Tl
(B10.129P2-Ifnb1tm1Tl)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:83021
|
Ifngtm1Ts/Ifngtm1Ts
(C.129S7-Ifngtm1Ts)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:34161
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:38363
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased susceptibility to experimental autoimmune uveoretinitis
|
J:99347
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * DBA/1OlaHsd)
|
increased susceptibility to induced arthritis
|
J:40634
|
Igh-Jtm1(CB20)Riho/Igh-J+
(involves: C57BL/10 * DBA/1)
|
increased susceptibility to induced arthritis
|
J:179456
|
Igh-Jtm1(CB20)Riho/Igh-Jtm1(CB20)Riho
(involves: C57BL/10 * DBA/1)
|
increased susceptibility to induced arthritis
|
J:179456
|
Igh-Jtm1Aigl/Igh-J+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:111543
|
Igh-Jtm1Aigl/Igh-J+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:111543
|
Igh-Jtm1Aigl/Igh-J+ Mogtm1Dpd/Mogtm1Dpd Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:151335
|
Igh-Jtm1Aigl/Igh-J+ Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:151335
|
Igh-Jtm1Aigl/Igh-Jtm1Aigl Tg(H2-Kb-Tcra,-Tcrb)1640Kurs/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N * SJL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:149511
|
Ighmtm1Cgn/Ighm+
(NOD.129S2-Ighmtm1Cgn)
|
increased susceptibility to autoimmune diabetes
|
J:37287
|
Ighmtm1Cgn/Ighm+ Tg(Igh-6/Igh-V125)2Jwt/0 Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)
|
increased susceptibility to autoimmune diabetes
|
J:91865
|
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas)
|
increased susceptibility to induced arthritis
|
J:157619
|
Ighmtm1Cgn/Ighmtm1Cgn Tg(Igh-VB1-8/Igh-6m)1Mjsk/?
(NODCaj.Cg-Ighmtm1Cgn Tg(Igh-VB1-8/Igh-6m)1Mjsk/FswJ)
|
increased susceptibility to autoimmune diabetes
|
J:93190
|
Ikzf4tm1.1Etms/Ikzf4tm1.1Etms
(Not Specified)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:295208
|
Il1r1em1Qizh/Il1r1em1Qizh
(C57BL/6-Il1r1em1Qizh)
|
increased susceptibility to induced arthritis
|
J:338375
|
Il1r1tm1Imx/Il1r1tm1Imx
(B6.129S7-Il1r1tm1Imx/J)
|
increased susceptibility to induced arthritis
|
J:125570
|
Il1rntm1.1Cga/Il1rntm1.1Cga Lyz2tm1(cre)Ifo/Lyz2+
(D1.Cg-Il1rntm1.1Cga Lyz2tm1(cre)Ifo)
|
increased susceptibility to induced arthritis
|
J:162760
|
Il2tm1Hor/Il2+
(NOD.129P2(B6)-Il2tm1Hor/DvsJ)
|
increased susceptibility to autoimmune diabetes
|
J:120349
|
Il2tm1Hor/Il2tm1Hor
(C.129P2-Il2tm1Hor)
|
increased susceptibility to autoimmune hemolytic anemia
|
J:29799
|
Il2tm1Hor/Il2tm1Hor
(B6.129P2-Il2tm1Hor/J)
|
increased susceptibility to autoimmune disorder
|
J:113547
|
Il2rbtm1Mak/Il2rbtm1Mak
(either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas))
|
increased susceptibility to autoimmune hemolytic anemia
|
J:25940
|
Il2rbtm1Mak/Il2rbtm1Mak
(B6.129-Il2rbtm1Mak)
|
increased susceptibility to autoimmune hemolytic anemia
|
J:113547
|
Il2rbtm1Mak/Il2rbtm1Mak
(C.129-Il2rbtm1Mak)
|
increased susceptibility to autoimmune hemolytic anemia
|
J:113547
|
Il4tm1Cgn/Il4tm1Cgn
(NOD.129P2-Il4tm1Cgn)
|
increased susceptibility to autoimmune disorder
|
J:95105
|
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:142883
|
Il9rtm1Jcrd/Il9rtm1Jcrd
(involves: C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:151907
|
Il15tm1Imx/Il15tm1Imx X/Yaa
(BXSB.B6-Il15tm1Imx/Dcr)
|
increased susceptibility to systemic lupus erythematosus
|
J:179430
|
Il17atm1Yiw/Il17atm1Yiw Tg(CD2-Rorc)#Staka/0
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:230700
|
Il21tm1Lex/Il21tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:137377
|
Il21rtm1Kopf/Il21rtm1Kopf
(B6.129-Il21rtm1Kopf)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:137377
|
Il25tm1Dart/Il25tm1Dart
(involves: C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:125296
|
Il27tm1Cua/Il27tm1Cua
(C57BL/6-Il27tm1Cua)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:147706
|
Il27ratm1Mak/Il27ratm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:151552
|
Imh1NZB/Imh1NZB
(involves: NZB * NZW)
|
increased susceptibility to systemic lupus erythematosus
|
J:26266
|
Imh1NZB/Imh1NZW
(involves: NZB * NZW)
|
increased susceptibility to systemic lupus erythematosus
|
J:22353
|
Ins1tm1Jja/Ins1tm1Jja Tg(Ins2*Y16A)1Ell/0
(NOD.Cg-Ins1tm1Jja Tg(Ins2*Y16A)1Ell)
|
increased susceptibility to autoimmune diabetes
|
J:98583
|
Ins2C95S/Ins2+
(C3HeB/FeJ-Ins2C95S)
|
increased susceptibility to autoimmune diabetes
|
J:122098
|
Ins2C95S/Ins2C95S
(C3HeB/FeJ-Ins2C95S)
|
increased susceptibility to autoimmune diabetes
|
J:122098
|
Irak3tm1Flv/Irak3tm1Flv
(NOD.129S1(B6)-Irak3tm1Flv)
|
increased susceptibility to autoimmune diabetes
|
J:229884
|
Irs1tm1Mfw/Irs1tm1Mfw Irs2tm2Mfw/Irs2tm2Mfw Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
increased susceptibility to autoimmune diabetes
|
J:137845
|
Irs1tm2Tka/Irs1tm2Tka Irs2tm2Tka/Irs2tm2Tka Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
|
increased susceptibility to autoimmune diabetes
|
J:137846
|
Junbtm3Wag/Junbtm3Wag Tg(KRT5-cre)1Tak/0
(involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:155575
|
Laq1MRL/Laq1MRL
(involves: C57BL/6 * MRL)
|
increased susceptibility to autoimmune disorder
|
J:45708
|
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas)
|
increased susceptibility to autoimmune hemolytic anemia
|
J:125722
|
Lbric-J/Lbr+
((NZW/LacJ x C57BL/6J-Lbric-J/J)F1)
|
increased susceptibility to systemic lupus erythematosus
|
J:234168
|
Lbw5NZW/LacScr/Lbw5NZB/BlScr
(involves: NZB/BlScr * NZW/LacScr)
|
increased susceptibility to systemic lupus erythematosus
|
J:20991
|
Lbw5NZW/LacScr/Lbw5NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr)
|
increased susceptibility to systemic lupus erythematosus
|
J:20991
|
Lbw6NZW/LacScr/Lbw6NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr)
|
increased susceptibility to systemic lupus erythematosus
|
J:20991
|
Lbw7NZB/BlScr/Lbw7NZB/BlScr
(involves: NZB/BlScr * NZW/LacScr)
|
increased susceptibility to systemic lupus erythematosus
|
J:20991
|
Lbw7NZB/BlScr/Lbw7NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr)
|
increased susceptibility to systemic lupus erythematosus
|
J:20991
|
Lbw8NZB/BlScr/Lbw8NZB/BlScr
(involves: NZB/BlScr * NZW/LacScr)
|
increased susceptibility to autoimmune disorder
|
J:20991
|
Lbw8NZB/BlScr/Lbw8NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr)
|
increased susceptibility to autoimmune disorder
|
J:20991
|
Lctlp1FVB/NJ/Lctlp1FVB/NJ
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:122919
|
Lctlp2FVB/NJ/Lctlp2FVB/NJ
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:122919
|
Leprdb/Leprdb
(involves: C57BLKS/J)
|
increased susceptibility to autoimmune diabetes
|
J:7005
|
Lgals1tm1Rob/Lgals1tm1Rob
(involves: 129S/SvEv)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:123416
|
Lgals9tm1Glp/Lgals9tm1Glp
(B6.129S6-Lgals9tm1Glp)
|
increased susceptibility to induced arthritis
|
J:132889
|
Lrch1em1Hwa/Lrch1em1Hwa
(Not Specified)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:238772
|
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:71174
|
Lyz2tm1(cre)Ifo/Lyz2tm1(cre)Ifo Nrrostm1Wouy/Nrrostm1Wouy
(involves: 129P2/OlaHsd)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:209569
|
Map4k1tm1Tht/Map4k1tm1Tht
(B6.129S7-Map4k1tm1Tht)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:116613
|
Mapk3tm1Gela/Mapk3tm1Gela
(either: 129(Cg)-Mapk3tm1Gela or B6.129-Mapk3tm1Gela)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:107504
|
Mbpshi/Mbpshi
(involves: BALB/c * C3HeB/Fe * SWV)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:48412
|
Mcph1Tg(HLA-A2.1)1Enge/Mcph1+
(NOD.B6-Mcph1Tg(HLA-A2.1)1Enge)
|
increased susceptibility to autoimmune diabetes
|
J:109851
|
Mcph1Tg(HLA-A2.1)1Enge/Mcph1Tg(HLA-A2.1)1Enge
(NOD.B6-Mcph1Tg(HLA-A2.1)1Enge)
|
increased susceptibility to autoimmune diabetes
|
J:109851
|
Mir125atm1Smoc/Mir125atm1Smoc
(involves: C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:224880
|
Mir140tm1.1Asah/Mir140tm1.1Asah
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased susceptibility to induced arthritis
|
J:160358
|
Mmp2tm1Ito/Mmp2tm1Ito
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:94099
|
Mogtm1(cre)Gkl/Mogtm1(cre)Gkl Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(C57BL/6-Mogtm1(cre)Gkl Tg(Tcra2D2,Tcrb2D2)1Kuch)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:151335
|
Mogtm1Dpd/Mogtm1Dpd Rag2tm1Cgn/Rag2tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:151335
|
Mogtm1Dpd/Mogtm1Dpd Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:151335
|
Mogtm1Reid/Mogtm1Reid
(B6.129S1/Sv-Mogtm1Reid)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:86663
|
Mogtm1Reid/Mogtm1Reid
(129/Sv-Mogtm1Reid)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:86663
|
Mpotm1Lus/Mpotm1Lus
(involves: 129X1/SvJ * C57BL/6J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:102965
|
Mr1tm1Gfn/Mr1tm1Gfn
(B6.129P2-Mr1tm1Gfn)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:112657
|
Mt1tm1Bri/Mt1tm1Bri Mt2tm1Bri/Mt2tm1Bri
(involves: 129S7/SvEvBrd)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:103102
|
Mta2tm1.1Yzha/Mta2tm1.1Yzha
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased susceptibility to systemic lupus erythematosus
|
J:137101
|
Mtus1Gt(RRA048)Byg/Mtus1Gt(RRA048)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:212144
|
Mtv7BALB/c/Mtv7BALB/c
(involves: B10.Q * BALB/c * DBA/2)
|
increased susceptibility to induced arthritis
|
J:27701
|
Muc19sld/Muc19sld
(NFS/N-Muc19sld)
|
increased susceptibility to autoimmune disorder
|
J:216958,
J:20364
|
Myl3tm1a(EUCOMM)Hmgu/Myl3tm1a(EUCOMM)Hmgu Tg(Col2a1-cre/ERT)KA3Smac/0
(involves: C57BL/6J * C57BL/6N * FVB/N)
|
increased susceptibility to induced arthritis
|
J:343166
|
Nba10NZB/Nba10NZB Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZB)
|
increased susceptibility to systemic lupus erythematosus
|
J:134128
|
Nba10NZB/Nba10NZB X/Yaa
(C57BL/6-Nba2 Yaa)
|
increased susceptibility to autoimmune disorder
|
J:95829
|
Nbwa1NZB/?
(involves: BALB/c * NZB * NZW)
|
increased susceptibility to systemic lupus erythematosus
|
J:88464
|
Nbwa2NZB/?
(involves: BALB/c * NZB * NZW)
|
increased susceptibility to systemic lupus erythematosus
|
J:88464
|
Nbwa2NZW/?
(involves: BALB/c * NZB * NZW)
|
increased susceptibility to systemic lupus erythematosus
|
J:88464
|
Ncf2tm1b(EUCOMM)Wtsi/Ncf2+
(NZM2328.B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi)
|
increased susceptibility to systemic lupus erythematosus
|
J:260777
|
Ncf2tm1b(EUCOMM)Wtsi/Ncf2tm1b(EUCOMM)Wtsi
(NZM2328.B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi)
|
increased susceptibility to systemic lupus erythematosus
|
J:260777
|
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to experimental autoimmune uveoretinitis
|
J:150597
|
Nfil3tm1.1Kubo/Nfil3tm1.1Kubo
(B6.Cg-Nfil3tm1.1Kubo)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:172134
|
Ngfrtm1Jae/Ngfrtm1Jae
(B6.129S4-Ngfrtm1Jae)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:112769
|
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd * PL/J)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:46192
|
Nr3c1tm2.1Gsc/Nr3c1+
(B6.129P2-Nr3c1tm2.1Gsc)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:137157
|
Nr3c1tm2Gsc/Nr3c1tm2Gsc Tg(Lck-cre)I57Jxm/0
(B6.Cg-Nr3c1tm2Gsc Tg(Lck-cre)I57Jxm)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:137157
|
Nrrostm1Lex/Nrrostm1Lex
(B6.129S5-Nrrostm1Lex)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:209569
|
Nudt7em1Ejj/Nudt7em1Ejj
(involves: C57BL/6N)
|
increased susceptibility to induced arthritis
|
J:266261
|
Otub1tm1c(EUCOMM)Hmgu/Otub1tm1c(EUCOMM)Hmgu Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
increased susceptibility to autoimmune disorder
|
J:280549
|
increased susceptibility to systemic lupus erythematosus
|
J:280549
|
Paam1MRL/MpJ/Paam1MRL/MpJ
(involves: C3H/HeJ * MRL/MpJ)
|
increased susceptibility to autoimmune disorder
|
J:76107
|
Paam2MRL/MpJ/Paam2MRL/MpJ
(involves: C3H/HeJ * MRL/MpJ)
|
increased susceptibility to autoimmune disorder
|
J:76107
|
Pdcd1tm1.1Shr/Pdcd1tm1.1Shr Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6)
|
increased susceptibility to autoimmune diabetes
|
J:153040
|
Pdcd1tm1Hon/Pdcd1tm1Hon Vsirtm1Lex/Vsirtm1Lex Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:222944
|
Pdcd1tm1Llc/Pdcd1tm1Llc
(involves: 129S5/SvEvBrd)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:126829
|
Pdcd1lg2tm3Shr/Pdcd1lg2tm3Shr
(involves: C57BL/6 * NOD/MrkTac)
|
increased susceptibility to autoimmune diabetes
|
J:123785
|
Pecam1tm1Mak/Pecam1+
(D1.129P2-Pecam1tm1Mak)
|
increased susceptibility to induced arthritis
|
J:106275
|
Pecam1tm1Mak/Pecam1tm1Mak
(D1.129P2-Pecam1tm1Mak)
|
increased susceptibility to induced arthritis
|
J:106275
|
Pgap3tm1.1Ymra/Pgap3tm1.1Ymra
(involves: 129 * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:181221
|
Pgia1BALB/cCrl/Pgia1DBA/2Crl
(involves: BALB/cCrl * DBA/2Crl)
|
increased susceptibility to autoimmune disorder
|
J:66460
|
Pgia13C3H/HeJCr/Pgia13C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:65424
|
Pgia14C3H/HeJCr/Pgia14C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:65424
|
Pgia15C3H/HeJCr/Pgia15C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:65424
|
Pgia16C3H/HeJCr/Pgia16C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:65424
|
Pgia39DBA/2Crl/Pgia39DBA/2Crl Pgia6DBA/2Crl/Pgia6DBA/2Crl
(involves: BALB/cCrl * DBA/2Crl)
|
increased susceptibility to induced arthritis
|
J:84150
|
Pgia39DBA/2Crl/Pgia39DBA/2Crl Pgia26BALB/cCrl/Pgia26BALB/cCrl
(involves: BALB/cCrl * DBA/2Crl)
|
increased susceptibility to induced arthritis
|
J:84150
|
Pgis1DBA/2/Pgis1DBA/2
(involves: BALB/c * DBA/2)
|
increased susceptibility to induced arthritis
|
J:107496
|
Pgis1DBA/2/Pgis1DBA/2 Pgis2BALB/c/Pgis2BALB/c
(involves: BALB/c * DBA/2)
|
increased susceptibility to induced arthritis
|
J:107496
|
Pgis1DBA/2/Pgis1DBA/2 Pgis2BALB/c/Pgis2DBA/2
(involves: BALB/c * DBA/2)
|
increased susceptibility to induced arthritis
|
J:107496
|
Pgis2BALB/c/Pgis2BALB/c
(involves: BALB/c * DBA/2)
|
increased susceptibility to induced arthritis
|
J:107496
|
Pgis2BALB/c/Pgis2DBA/2
(involves: BALB/c * DBA/2)
|
increased susceptibility to induced arthritis
|
J:107496
|
Pglyrp1tm1Rdz/Pglyrp1tm1Rdz
(C.129S-Pglyrp1tm1Rdz)
|
increased susceptibility to induced arthritis
|
J:178054
|
plt/plt
(either: B6.DDD-plt or C.DDD-plt)
|
increased susceptibility to autoimmune disorder
|
J:110910
|
Polbtm1.1Jbsw/Polbtm1.1Jbsw
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:206872
|
Ppargtm1Tka/Pparg+
(involves: C57BL/6 * CBA * ICR)
|
increased susceptibility to induced arthritis
|
J:58222
|
Ppargtm2Rev/Ppargtm2Rev Tg(Cd4-cre)1Cwi/?
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:153358
|
Prkcitm1Rfar/Prkci+ Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
increased susceptibility to autoimmune diabetes
|
J:123964
|
Prkdcscid/Prkdcscid Tg(Ins2-Fasl)24Ach/0
(NOD.Cg-Prkdcscid Tg(Ins2-Fasl)24Ach)
|
increased susceptibility to autoimmune diabetes
|
J:81416
|
Prkdcscid/Prkdcscid Tg(INS-Il10)#Sar/0
(NOD.Cg-Prkdcscid Tg(INS-Il10)#Sar)
|
increased susceptibility to autoimmune diabetes
|
J:66103
|
Prkdcscid/Prkdcscid Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0
(NOD.Cg-Prkdcscid Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)
|
increased susceptibility to autoimmune diabetes
|
J:93553
|
Psen1tm1Bdes/Psen1+ Psen2tm1Bdes/Psen2tm1Bdes
(involves: 129P2/OlaHsd)
|
increased susceptibility to autoimmune disorder
|
J:91235
|
Ptprctm1Weis/Ptprc+
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:66501
|
Ptprctm1Weis/Ptprctm1Weis
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:66501
|
Ptprntm1Aln/Ptprntm1Aln
(NOD.129S4-Ptprntm1Aln)
|
increased susceptibility to autoimmune diabetes
|
J:107161
|
Ptprz1tm1Schl/Ptprz1tm1Schl
(involves: 129 * Swiss Webster)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:79860
|
Rag1tm1Mom/Rag1tm1Mom Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0
(NOD.Cg-Rag1tm1Mom Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs/Dvs)
|
increased susceptibility to autoimmune diabetes
|
J:94192
|
Rag1tm1Mom/Rag1tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
increased susceptibility to autoimmune diabetes
|
J:111874
|
Rasgrp1lag/Rasgrp1lag
(involves: 129 * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:85189
|
Rnf128tm1Cdon/Rnf128+
(involves: 129 * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:160681
|
Rnf128tm1Cdon/Rnf128tm1Cdon
(involves: 129 * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:160681
|
Rubcnem1Dgre/Rubcnem1Dgre
(involves: C57BL/6 * C57BL/6N)
|
increased susceptibility to systemic lupus erythematosus
|
J:235399
|
Satb1tm2Kos/Satb1tm2Kos Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
increased susceptibility to autoimmune disorder
|
J:252606
|
Scarf1tm1Tkms/Scarf1tm1Tkms
(involves: C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:208237
|
Secia1DBA/1J/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Secia2DBA/1J/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Secia3FVB/NJ/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Secia4DBA/1J/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Secia5DBA/1J/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Secia6DBA/1J/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Secia7FVB/NJ/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Secia8FVB/NJ/?
(involves: DBA/1J * FVB/NJ)
|
increased susceptibility to induced arthritis
|
J:123131
|
Selptm1Bay/Selptm1Bay
(D1.129S7(B6J)-Selptm1Bay)
|
increased susceptibility to induced arthritis
|
J:57086
|
Senp1tm1Wami/Senp1tm1Wami Tg(Fabp4-cre)#Abel/0
(B6.Cg-Senp1tm1Wami Tg(Fabp4-cre)#Abel)
|
increased susceptibility to autoimmune diabetes
|
J:228009
|
Sit1tm1Lsmn/Sit1tm1Lsmn
(B6.Cg-Sit1tm1Lsmn)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:100408
|
Sle1NZW/Sle1NZW Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZW)
|
increased susceptibility to systemic lupus erythematosus
|
J:134128
|
Sle6NZW/Sle6NZW
(involves: C57BL/6 * NZW)
|
increased susceptibility to systemic lupus erythematosus
|
J:57246
|
Sle16129S6/SvEvTac/Sle16129S6/SvEvTac
(B6.129-Sle16129S6/SvEvTac)
|
increased susceptibility to systemic lupus erythematosus
|
J:122132
|
Sles1C57BL/6/Sles1C57BL/6
(involves: C57BL/6 * NZW)
|
increased susceptibility to systemic lupus erythematosus
|
J:57246
|
Sles2C57BL/6/Sles2C57BL/6
(involves: C57BL/6 * NZW)
|
increased susceptibility to systemic lupus erythematosus
|
J:57246
|
Sles2C57BL/6/Sles2NZW
(involves: C57BL/6 * NZW)
|
increased susceptibility to systemic lupus erythematosus
|
J:57246
|
Sles3C57BL/6/Sles3C57BL/6
(involves: C57BL/6 * NZW)
|
increased susceptibility to systemic lupus erythematosus
|
J:57246
|
Sles3C57BL/6/Sles3NZW
(involves: C57BL/6 * NZW)
|
increased susceptibility to systemic lupus erythematosus
|
J:57246
|
Sles4C57BL/6/Sles4C57BL/6
(involves: C57BL/6 * NZW)
|
increased susceptibility to systemic lupus erythematosus
|
J:57246
|
Sles4C57BL/6/Sles4NZW
(involves: C57BL/6 * NZW)
|
increased susceptibility to systemic lupus erythematosus
|
J:57246
|
Socs3tm1Robb/Socs3tm1Robb
(involves: C57BL/6)
|
increased susceptibility to induced arthritis
|
J:145513
|
Sod3tm1Mrkl/Sod3tm1Mrkl
(D1.129P2-Sod3tm1Mrkl)
|
increased susceptibility to induced arthritis
|
J:106273
|
Stat4tm1Jni/Stat4tm1Jni Stat6tm1Jni/Stat6tm1Jni
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
increased susceptibility to autoimmune diabetes
|
J:96338
|
Stim1tm1Kuro/Stim1tm1Kuro Stim2tm1.1Kuro/Stim2tm1.1Kuro Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:172608
|
Syt7tm1Nan/Syt7tm1Nan
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:85201
|
Tap1tm1Arp/Tap1tm1Arp X/Yaa
(BXSB.129S2(B6)-Tap1tm1Arp/Dcr)
|
increased susceptibility to systemic lupus erythematosus
|
J:179430
|
Tbc1d10ctm1.1Psou/Tbc1d10ctm1.2Psou Cd79atm1(cre)Reth/Cd79a+
(involves: 129S2/SvPas * BALB/c * C57BL/6J)
|
increased susceptibility to systemic lupus erythematosus
|
J:211913
|
Tbc1d10ctm1.2Psou/Tbc1d10ctm1.2Psou
(involves: 129S2/SvPas * C57BL/6J)
|
increased susceptibility to systemic lupus erythematosus
|
J:211913
|
Tet1tm1.2Jae/Tet1tm1.2Jae Tet2tm1.1Iaai/Tet2tm1.1Iaai Tet3tm1.1Yzhg/Tet3tm1.1Yzhg Tg(Rorc-cre)1Litt/0
(involves: 129 * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB)
|
increased susceptibility to autoimmune disorder
|
J:333574
|
Tg(BCL2)22Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
increased susceptibility to autoimmune disorder
|
J:93111
|
Tg(BCL2)36Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
increased susceptibility to autoimmune disorder
|
J:93111
|
Tg(CD2-Rorc)#Staka/0
(involves: C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:230700
|
Tg(Cd2-Smad7)#Chbe/0
(involves: C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:184670
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:217939
|
Tg(Cd4-CD4)2362Litt/0 Tg(HLA-DR2)#Lfug/0 Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2 * SJL)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:134764
|
Tg(CD4-Il17re)#Cdon/0
(involves: C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:177650
|
Tg(Cd152Ig)1Jbs/0
(involves: C3H * NOD)
|
increased susceptibility to autoimmune diabetes
|
J:35353
|
Tg(Emu-TXLNA)1Amjr/0
(B6.Cg-Tg(Emu-TXLNA)1Amjr)
|
increased susceptibility to autoimmune disorder
|
J:117018,
J:145185
|
Tg(FCGR2A)11Mkz/Tg(FCGR2A)11Mkz
(involves: C57BL/6 * SJL)
|
increased susceptibility to induced arthritis
|
J:136516
|
Tg(H2-Ea-G6pc2)69Tkay/?
(NOD-Tg(H2-Ea-G6pc2)69Tkay)
|
increased susceptibility to autoimmune diabetes
|
J:117352
|
Tg(H2-Kb-Tcra,-Tcrb)1640Kurs/0
(SJL.FVB-Tg(H2-Kb-Tcra,-Tcrb)1640Kurs)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:149511
|
Tg(HLA-A/H2-D/B2M)1Dvs/0
(NOD/ShiLtDvs-Tg(HLA-A/H2-D/B2M)1Dvs)
|
increased susceptibility to autoimmune diabetes
|
J:121685
|
Tg(HLA-DR2)#Lfug/0 Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:134764
|
Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz/Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz
(involves: C57BL/6 * C57BL/10Sn * SJL/J)
|
increased susceptibility to induced arthritis
|
J:108635
|
Tg(Igh-6/Igh-V125)2Jwt/0 Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.B6-Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)
|
increased susceptibility to autoimmune diabetes
|
J:91865
|
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg
(NOD.B6-Tg(IghelMD4)4Ccg/DvsJ)
|
increased susceptibility to autoimmune diabetes
|
J:80859
|
Tg(IghH280)48Dvs/?
(NOD/ShiLtDvs-Tg(IghH280)48Dvs/J)
|
increased susceptibility to autoimmune diabetes
|
J:274578
|
Tg(IghH280)48Dvs/? Tg(IgkH280)934Dvs/?
(NOD/ShiLtDvs-Tg(IghH280)48Dvs Tg(IgkH280)934Dvs/Dvs)
|
increased susceptibility to autoimmune diabetes
|
J:274578
|
Tg(IgkH280)934Dvs/?
(NOD/ShiLtDvs-Tg(IgkH280)934Dvs/J)
|
increased susceptibility to autoimmune diabetes
|
J:274578
|
Tg(Ins1-Cat,Tyr)25Pne/0
(NOD.FVB-Tg(Ins1-Cat,Tyr)25Pne)
|
increased susceptibility to autoimmune diabetes
|
J:108415
|
Tg(Ins1-EGFP/GH1)14Hara/0
(NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara)
|
increased susceptibility to autoimmune diabetes
|
J:127015
|
Tg(Ins2*Y16A)1Ell/0
(NOD-Tg(Ins2*Y16A)1Ell)
|
increased susceptibility to autoimmune diabetes
|
J:98583
|
Tg(Ins2*Y16A)3Ell/0
(NOD-Tg(Ins2*Y16A)3Ell)
|
increased susceptibility to autoimmune diabetes
|
J:98583
|
Tg(Ins2-CD80)3B7Flv/?
(involves: C57BL/6 * CBA/Ca * NOD/Caj)
|
increased susceptibility to autoimmune diabetes
|
J:26618
|
Tg(Ins2-CD80)3B7Flv/0 Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL)
|
increased susceptibility to autoimmune diabetes
|
J:93555
|
Tg(Ins2-CD80)3B7Flv/0 Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA/Ca)
|
increased susceptibility to autoimmune diabetes
|
J:93555
|
Tg(Ins2-CD86)12B70Flv/0 Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL)
|
increased susceptibility to autoimmune diabetes
|
J:93555
|
Tg(Ins2-CD86)12B70Flv/0 Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA/Ca)
|
increased susceptibility to autoimmune diabetes
|
J:93555
|
Tg(Ins2-Cd274)2Mdos/?
(NOD/ShiLt-Tg(Ins2-Cd274)2Mdos)
|
increased susceptibility to autoimmune diabetes
|
J:118934
|
Tg(Ins2-cre)5Lt/0
(NOD/ShiLt-Tg(Ins2-cre)5Lt)
|
increased susceptibility to autoimmune diabetes
|
J:127015
|
Tg(Ins2-crmA)27Ngkh/?
(NOD-Tg(Ins2-CrmA)27Ngkh)
|
increased susceptibility to autoimmune diabetes
|
J:132052
|
Tg(Ins2-Fasl)24Ach/0
(NOD-Tg(Ins2-Fasl)24Ach/J)
|
increased susceptibility to autoimmune diabetes
|
J:78679,
J:81416
|
Tg(Ins2-GP)34-20Olds/0
(involves: BALB/c * C57BL/6)
|
increased susceptibility to autoimmune diabetes
|
J:81287
|
Tg(Ins2-IAPP)RHFSoel/Tg(Ins2-IAPP)RHFSoel
(involves: FVB/N)
|
increased susceptibility to autoimmune diabetes
|
J:130022
|
Tg(Ins2-NP)25-3Olds/0
(involves: BALB/c * C57BL/6)
|
increased susceptibility to autoimmune diabetes
|
J:81287
|
Tg(Ins2-OVA)59Wehi/?
(involves: BALB/c * C57BL/6)
|
increased susceptibility to autoimmune diabetes
|
J:99560
|
Tg(Ins2-OVA)307Wehi/?
(involves: BALB/c * C57BL/6)
|
increased susceptibility to autoimmune diabetes
|
J:99560
|
Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: C57BL/6)
|
increased susceptibility to autoimmune diabetes
|
J:122114
|
Tg(INS-Il10)#Sar/0 Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6J * NOD)
|
increased susceptibility to autoimmune diabetes
|
J:64051
|
Tg(INS-Il10)#Sar/0 Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6J * NOD)
|
increased susceptibility to autoimmune diabetes
|
J:64051
|
Tg(KRT5-rtTA)1Glk/0 Tg(tetO/CMV-Tslp)#Sfz/0
(C.Cg-Tg(KRT5-rtTA)1Glk Tg(tetO/CMV-Tslp)#Sfz)
|
increased susceptibility to autoimmune hemolytic anemia
|
J:182756
|
Tg(Lck-Stk17b)26.1Wals/?
(B6.Cg-Tg(Lck-Stk17b)26.1Wals)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:149973
|
Tg(Lck/Emu-Rftn1)1Ayos/?
(involves: C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:150299
|
Tg(Psp-Rbbp4)1Yoha/0
(involves: C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:141378
|
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:83278
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:83278
|
Tg(Tcra,Tcrb)24Efro/0
(D1.Cg-Tg(Tcra,Tcrb)24Efro)
|
increased susceptibility to autoimmune disorder
|
J:104243
|
Tg(TcraAI4)1Dvs/0
(NOD-Tg(TcraAI4)1Dvs)
|
increased susceptibility to autoimmune diabetes
|
J:93553
|
Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0
(NOD-Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)
|
increased susceptibility to autoimmune diabetes
|
J:94192
|
Tg(TcraTcrbNY4.1)1Pesa/0
(NOD.Cg-Tg(TcraTcrbNY4.1)1Pesa)
|
increased susceptibility to autoimmune diabetes
|
J:108768
|
Tg(TcrbBL17)1Lmor/0
(involves: DBA/1J * SWR/J)
|
increased susceptibility to induced arthritis
|
J:134111
|
Tg(TcrbBL17)1Lmor/Tg(TcrbBL17)1Lmor
(involves: DBA/1J * SWR/J)
|
increased susceptibility to induced arthritis
|
J:134111
|
Tgfb1tm3.1Flv/Tgfb1tm3.1Flv Tg(Cd4-cre)1Cwi/0 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD * SJL)
|
increased susceptibility to autoimmune diabetes
|
J:196160
|
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm Tg(Cd4-cre)1Cwi/0 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD * SJL)
|
increased susceptibility to autoimmune diabetes
|
J:196160
|
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm Tnfrsf4tm2(cre)Nik/Tnfrsf4+ Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129 * C57BL/6 * NOD * SJL)
|
increased susceptibility to autoimmune diabetes
|
J:196160
|
TgTn(pb-CAG-Gm614)#Cya/0
(involves: C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:307345
|
Thop1Gt(CSG163)Byg/Thop1Gt(CSG163)Byg
(B6.129P2-Thop1Gt(CSG163)Byg)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:290567
|
Tigittm1Sdl/Tigittm1Sdl
(involves: C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:168902
|
Tigittm1Sdl/Tigittm1Sdl Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:168902
|
Timd4tm1Kuch/Timd4tm1Kuch
(involves: C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:235399
|
Tlr4Lps-d/Tlr4Lps-d
(involves: C3H/HeJ)
|
increased susceptibility to induced arthritis
|
J:96356
|
Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to autoimmune diabetes
|
J:158055
|
Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu)
|
increased susceptibility to systemic lupus erythematosus
|
J:324448
|
Tlr7em2Anu/Tlr7em2Anu
(C57BL/6NCrl-Tlr7em2Anu)
|
increased susceptibility to systemic lupus erythematosus
|
J:324448
|
Tmem178tm1Lex/Tmem178tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to induced arthritis
|
J:228311
|
Tnfaip3tm2Ama/Tnfaip3tm2Ama Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to autoimmune disorder
|
J:163917
|
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:92470
|
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak Tnip1Gt(E059E05)Wrst/Tnip1Gt(E059E05)Wrst
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:180054
|
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:115225
|
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(B6.129-Tnfsf10tm1Mjs)
|
increased susceptibility to autoimmune diabetes
|
J:82145
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:101672
|
increased susceptibility to induced arthritis
|
J:82145
|
Tnip1Gt(E059E05)Wrst/Tnip1Gt(E059E05)Wrst
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:180054
|
Trex1em3Gpt/Trex1em3Gpt
(C57BL/6JGpt-Trex1em3Gpt)
|
increased susceptibility to autoimmune disorder
|
J:330879
|
Trex1tm1.1Fwpe/Trex1tm1.1Fwpe
(involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac)
|
increased susceptibility to systemic lupus erythematosus
|
J:220965
|
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to systemic lupus erythematosus
|
J:181257
|
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to autoimmune disorder
|
J:243357
|
Tusc2tm1Avi/Tusc2+
(involves: 129S1/Sv * C57BL/6J)
|
increased susceptibility to autoimmune disorder
|
J:119985
|
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J)
|
increased susceptibility to autoimmune disorder
|
J:119985
|
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv)
|
increased susceptibility to autoimmune disorder
|
J:309768
|
Ubash3btm1Jni/Ubash3btm1Jni Ubash3atm1Jni/Ubash3atm1Jni
(Not Specified)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:89761
|
Usp25Gt(RRS805)Byg/Usp25Gt(RRS805)Byg
(involves: 129P2/OlaHsd)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:188557
|
Vdrtm1Ska/Vdrtm1Ska
(NOD.Cg-Vdrtm1Ska/CmatJ)
|
increased susceptibility to autoimmune diabetes
|
J:127787
|
Vsig4tm1Gne/Vsig4tm1Gne
(C57BL/6-Vsig4tm1Gne)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:281762
|
Vsirtm1Lex/Vsirtm1Lex Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:222944
|
Vtcn1tm1Xxz/Vtcn1tm1Xxz
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
increased susceptibility to autoimmune diabetes
|
J:177612
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:177612
|
Vwftm1Wgr/Vwftm1Wgr
(B6.129S2-Vwftm1Wgr)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:140334
|
X/Yaa
((NZB x BXSB)F1)
|
increased susceptibility to autoimmune disorder
|
J:6235
|
X/Yaa
((SJL/J x BXSB)F1)
|
increased susceptibility to autoimmune disorder
|
J:6235
|
X/Yaa
((C57BL/6J x BXSB)F1)
|
increased susceptibility to autoimmune disorder
|
J:6235
|
X/Yaa
(involves: BXSB * NZB)
|
increased susceptibility to autoimmune disorder
|
J:6235
|
X/Yaa
(BXSB/MpJ)
|
increased susceptibility to autoimmune disorder
|
J:108760,
J:6235
|
X/Yaa
((NZW x SB)F1)
|
increased susceptibility to autoimmune disorder
|
J:7276
|
X/Yaa
((NZW x BXSB)F1)
|
increased susceptibility to autoimmune disorder
|
J:7276
|
X/Yaa
(BXSB/MpJScr)
|
increased susceptibility to autoimmune disorder
|
J:10973
|
Zap70m1Saka/Zap70m1Saka
(involves: BALB/c)
|
increased susceptibility to induced arthritis
|
J:154166
|
Zc3h12dtm1Tom/Zc3h12dtm1Tom
(B6.Cg-Zc3h12dtm1Tom)
|
increased susceptibility to experimental autoimmune encephalomyelitis
|
J:209383
|